U.K. Biotechnology & Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Consulting, Regulatory Affairs), By End-use (Pharma, Biotech), And Segment Forecasts, 2021 - 2028

Table of Contents

Chapter 1 Methodology and Scope
                 1.1 Market Segmentation & Scope
                       1.1.1 Estimates And Forecast Timeline
                 1.2 Research Methodology
                 1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 Gvr’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                 1.4 Information Or Data Analysis
                       1.4.1 Data Analysis Models
                 1.5 Market Formulation & Validation
                 1.6 Region Wise Market Calculation
                       1.6.1 Region Wise Market: Base Estimates
                       1.6.2 Global Market: CAGR Calculation
                 1.7 List of Secondary Sources
                 1.8 Objectives
                       1.8.1 Objective - 1: Understanding market dynamics
                       1.8.2 Objective - 2: Understanding market estimates and forecasts
                       1.8.3 Objective - 3: Understanding attributes such as strategy framework and competitor categorization
                       1.8.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size.
Chapter 2 Executive Summary
                 2.1 Market Outlook
Chapter 3 U.K. Biotechnology & Pharmaceutical Service Outsourcing Market: Variables, Trends, & Scope
                 3.1 Market Segmentation and Scope
                 3.2 Market Dynamics
                       3.2.1 Market Driver Analysis
                            3.2.1.1 Increasing outsourcing of R&D activities
                            3.2.1.2 Changing regulatory landscape
                            3.2.1.3 Growing drug development costs coupled with high clinical development failure rates
                            3.2.1.5 Increasing mergers and collaborations
                       3.2.2 Market Restraint Analysis
                            3.2.2.1 Monitoring issues and lack of standardization
                            3.2.2.2 Loss of control
                            3.2.2.3 Data security issues
                 3.3 Penetration & Growth Prospect Mapping
                 3.4 COVID - 19 Impact on the Market
                 3.5 Major Deals and Strategic Alliances Analysis
                 3.6 U.K. Biotechnology & Pharmaceutical Service Outsourcing: Market Analysis Tools
                       3.6.1 Industry Analysis - Porter’s
                       3.6.3 PESTEL Analysis
Chapter 4 U.K. Biotechnology & Pharmaceutical Service Outsourcing Market: Service Segment Analysis
                 4.1 U.K. Biotechnology & Pharmaceutical Service Outsourcing Market: Service Market Share Analysis, 2020 & 2028
                 4.2 Consulting Services
                       4.2.1 Consulting Services Market, 2016 - 2028 (USD Million)
                 4.3 Auditing & assessment
                       4.3.1 Auditing & assessment Market, 2016 - 2028 (USD Million)
                 4.4 Regulatory affairs
                       4.4.1 Regulatory affairs Market, 2016 - 2028 (USD Million)
                 4.5 Product maintenance
                       4.5.1 Product maintenance Market, 2016 - 2028 (USD Million)
                 4.6 Product design & development
                       4.6.1 Product design & development Market, 2016 - 2028 (USD Million)
                 4.7 Product testing & validation
                       4.7.1 Product testing & validation Market, 2016 - 2028 (USD Million)
                 4.8 Training & education
                       4.8.1 Training & education Market, 2016 - 2028 (USD Million)
                 4.9 Others
                       4.9.1 Others Market, 2016 - 2028 (USD Million)
Chapter 5 U.K. Biotechnology & Pharmaceutical Service Outsourcing Market: End use Segment Analysis
                 5.1 U.K. Biotechnology & Pharmaceutical Service Outsourcing Market: End - use Market Share Analysis, 2020 & 2028
                 5.2 Pharmaceutical
                       5.2.1 Pharmaceutical Market, 2016 - 2028 (USD Million)
                 5.3 Biotech
                       5.3.1 Biotech Market, 2016 - 2028 (USD Million)
Chapter 6 Company Profiles
                 6.1 The Quantic Group
                       6.1.1 Company Overview
                       6.1.2 Service Benchmarking
                       6.1.3 Financial Performance
                       6.1.4 Strategic Initiatives
                 6.2 Iqvia Holdings, Inc
                       6.2.1 Company Overview
                       6.2.2 Financial Performance
                       6.2.3 Service Benchmarking
                       6.2.4 Strategic Initiatives
                 6.3 Parexel International Corporation
                       6.3.1 Company Overview
                       6.3.2 Service Benchmarking
                       6.3.3 Strategic Initiatives
                 6.4 Lachman Consultant Services
                       6.4.1 Company Overview
                       6.4.2 Financial Performance
                       6.4.3 Service Benchmarking
                 6.5 GMP Pharmaceuticals
                       6.5.1 Company Overview
                       6.5.2 Financial Performance
                       6.5.3 Service Benchmarking
                 6.6 Concept Heidelberg GmbH
                       6.6.1 Company Overview
                       6.6.2 Financial Performance
                       6.6.3 Service Benchmarking
                 6.7 Covance, INC.
                       6.7.1 Company Overview
                       6.7.2 Financial Performance
                       6.7.3 Service Benchmarking
                       6.7.4 Strategic Initiatives
                 6.8 PRA Health Sciences
                       6.8.1 Company Overview
                       6.8.2 Financial Performance
                       6.8.3 Service Benchmarking
                 6.9 Charles River Laboratories
                       6.9.1 Company Overview
                       6.9.2 Financial Performance
                       6.9.3 Service Benchmarking
                       6.9.4 Strategic Initiatives
                 6.10 ICON plc
                       6.10.1 Company Overview
                       6.10.2 Financial Performance
                       6.10.3 Service Benchmarking
                       6.10.4 Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.K. Biotechnology & Pharmaceutical Services Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 4 U.K. Biotechnology & Pharmaceutical Services Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 5 U.K. Biotechnology & Pharmaceutical Consulting Services Market, by Service, 2016 - 2028 (USD Million)
Table 6 U.K. Biotechnology & Pharmaceutical Regulatory Affairs Services Market, by Service, 2016 - 2028 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in Europe
Fig. 5 Market research approaches
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 U.K. Biotechnology/pharmaceutical services outsourcing market snapshot (2020)
Fig. 10 U.K. Biotechnology/pharmaceutical services outsourcing market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Pharmaceutical R&D spending, 2015-2024 (USD billion)
Fig. 13 Average cost per new drug development, 2000 - 2011 (USD Million)
Fig. 14 Failure rates in phase transitions during drug development
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Penetration & growth prospect mapping
Fig. 17 Porter’s five forces analysis
Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 19 Reasons behind outsourcing
Fig. 20 Percentage of outsourcing of different functions
Fig. 21 Selection parameters
Fig. 22 Heat map for pricing models opted by competitors
Fig. 23 Companies with affected trials, by size
Fig. 24 Affected trials, by study phase
Fig. 25 COVID-19 trials, 2020
Fig. 26 U.K. Biotechnology/pharmaceutical services outsourcing market stage outlook: Segment dashboard
Fig. 27 U.K. Biotechnology/pharmaceutical services outsourcing market: Service movement analysis
Fig. 28 Consulting market, 2016 - 2028 (USD Million)
Fig. 29 Regulatory compliance market, 2016 - 2028 (USD Million)
Fig. 30 Remediation market, 2016 - 2028 (USD Million)
Fig. 31 Quality management systems consulting market, 2016 - 2028 (USD Million)
Fig. 32 Others market, 2016 - 2028 (USD Million)
Fig. 33 Auditing and assessment market, 2016 - 2028 (USD Million)
Fig. 34 Regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 35 Clinical trial applications & product registration market, 2016 - 2028 (USD Million)
Fig. 36 Regulatory writing & publishing market, 2016 - 2028 (USD Million)
Fig. 37 Legal representation market, 2016 - 2028 (USD Million)
Fig. 38 Others market, 2016 - 2028 (USD Million)
Fig. 39 Product maintenance market, 2016 - 2028 (USD Million)
Fig. 40 Product design & development market, 2016 - 2028 (USD Million)
Fig. 41 Product testing & validation market, 2016 - 2028 (USD Million)
Fig. 42 Training & education market, 2016 - 2028 (USD Million
Fig. 43 Others market, 2016 - 2028 (USD Million)
Fig. 44 U.K. Biotechnology/pharmaceutical services outsourcing market end-use outlook: Segment dashboard
Fig. 45 U.K. Biotechnology/pharmaceutical services outsourcing market: End-use movement analysis
Fig. 46 Pharmaceutical companies market, 2016 - 2028 (USD Million)
Fig. 47 Biotech companies market, 2016 - 2028 (USD Million)
Fig. 48 Strategic Map